The Gilead Sciences Research Scholars Program provides financial support to junior faculty researchers for two years. Dr. Quan Xie, a faculty member in the Department of Biomedical Sciences at Quillen, received $130,000 in funding from the program to study hepatocellular carcinoma, the most common type of liver cancer in adults.
Xie’s research relates to the use of genetically modified T-cells and their potential to halt tumor growth and possibly extend life expectancy.
In being named a Gilead Research Scholar in Liver Disease, Xie was recognized for her research proposal, which was evaluated for innovation and significance, approach and feasibility by a committee comprised of internationally recognized efforts in basic and clinical research in the field of liver disease.
She and three others were selected for funding out of more than 55 applicants within the United States.
In addition to serving as an assistant professor at Quillen, Xie is a member of ETSU’s Center of Excellence in Inflammation, Infectious Disease and Immunity.